Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer

International Journal of Colorectal Disease

Volumn 27, Issue 10, 2012, Pages 1369-1376

  Formentini, Andrea ^a   Braun, Philipp ^a   Fricke, Harald ^b   Link, Karl Heinrich ^c   Henne Bruns, Doris ^a   Kornmann, Marko ^a  

^a UNIVERSITY OF ULM   (Germany)

^b APOGENIX GMBH   (Germany)

^c Asklepios Paulinen Klinik   (Germany)

Author keywords

Colorectal cancer; Interleukin 13; Interleukin 13 receptor; Interleukin 4; Interleukin 4 receptor

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CLASSIFICATION; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; REGRESSION ANALYSIS;

EID: 84866995000     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1456-0     Document Type: Article

References (29)

1. Terabe M, Park JM, Berzofsky JA (2004) Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother 53:79-85
2. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ (1996) cDNA cloning and characterisation of the human interleukin 13 receptor alpha chain. J Biol Chem 271:29265-29270
3. da Idzer RL, March CJ, Mosley B, Lyman SD, Van den Bos T, Gumpel SD, Din WS, Grabstein KH, Widmer MB, Park LS (1990) Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 171:861-873
4. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P (1996) Cloning and characterisation of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271:16921-16926
5. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-74
6. Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL (2011) 2011: the immune hallmarks of cancer. Cancer Immunol Immunother 60:319-26
7. Klampfer L (2011) Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 11:451-464
8. Formentini A, Prokopchuk O, Straeter J, Kleef J, Grochola LF, Leder G, Henne-Bruns D, Korc M, Kornmann M (2009) Interleukin 13 exerts autocrine growth promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastasis. Int J Colorectal Dis 24:57-67
9. Prokopchuk O, Liu Y, Henne-Bruns D, Kornmann M (2005) Interleukin 4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Br J Cancer 92:921-928
10. Kanai T, Watanabe M, Hayashi H, Nakazawa A, Yajima T, Okazawa A, Yamazaki M, Ishii H, Hibi T (2000) Regulatory effect of interleukin 4 and interleukin 13 on colon cancer cell adhesion. Br J Cancer 82(10):1717-23
11. Staib L, Kornmann M, Link KH (2010) Adjuvant therapy in colorectal cancer-studies of the FOGT group. BMC Proceedings 4(Suppl 2):O27
12. Knörr C, Amrehn C, Seeberger H, Rosenwald A, Stilgenbauer S, Ott G, Müller Hermelink HK, Greiner A (1999) Expression of costimulatory molecules in low-grade mucosa associated lymphoid tissue-type lymphomas in vivo. Am J Pathol 155:2019-2027
13. Lama VN, Harada H, Badri LN, Flint A, Hogaboam CM, McKenzie A,Martinez FJ, Toews GB,Moore BB, Pinsky DJ (2006) Obligatory role for interleukin 13 in obstructive lesion development in airway allograft. Am J Pathol 169:47-60
14. Oliveira M, Fraga C, Gomez RS, Paula AM (2009) Immunohistochemical expression of interleukin-4, -6, -8 and -12 in inflammatory cells in surrounding invasive front of oral squamous cell carcinoma. Head Neck 31:1439-1446
15. Mandruzzato S (2006) A gene expression signature associated with survival in metastatic melanoma. J Transl Med 4:50
16. Formentini A, Sander S, Denzer S, Sträter J, Henne-Bruns D, Kornmann M (2007) Thymidylate synthase expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker ? Int J Colorectal Dis 22:49-55
17. Mandal D, Levine AD (2010) Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancers initiates MAPK pathway. Inflamm Bowel Dis 16:753-764
18. Joshi BH, Puri RK (2009) IL-13 receptor α2: a novel target for cancer therapy. Immunotherapy 1:321-327
19. Li Z, Chen L, Qin Z (2009) Paradoxical roles of IL-4 in tumor immunity. Cell Mol Immunol 6:415-422
20. Srabovici N, Mujagic Z, Mujanovic-Mustedanagic J, Muminovic Z, Softic A, Begic L (2011) Interleukin 13 expression in the primary breast cancer tumour tissue. Biochem Med (Zagreb) 21:131-138
21. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Berzofsky JA (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1:515-520
22. Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA (2003) TGFb production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block CTL-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 198:1741-52
23. Blais Y, Gingras S, Haagensen DE, Labrie F, Simard J (1996) Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol Cell Endocrinol 121:11-18
24. Serve H, Oelmann E, Herweg A, Oberberg D, Serve S, Reufi B, Mücke C, Minty A, Thiel E, Berdel WE (1996) Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res 56:3583-3588
25. Obiri NI, Husain SR, Debinski W, Puri RK (1996) Interleukin 13 inhibits growth of the human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain. Clin Cancer Res 2:1743-1749
26. Renard N, Duvert V, Banchereau J, Saeland S (1994) Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood 84:2253-2260
27. Ma HL, Whitters MJ, Jacobson BA, Donaldson DD, Collins M, Donussi-Joannopoulos K (2004) Tumor cells secreting ILα13 but not ILα13Rα2 fusion protein have reduced tumorigenicity in vivo. Int Immunol 16:1009-1017
28. Lebel-Binay S, Laguerre B, Quintin-Colonna F, Conjeaud H, Magazin M, Miloux B, Pecceu F, Caput D, Ferrara P, Fradelizi D (1995) Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin 13. Eur J Immunol 25:2340-8
29. Barth RJ, Camp BJ, Martuscello TA, Dain BJ, Memoli VA (1996) The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin 4 predicts improved survival. Cancer 78:1168-1178